Steffen Borrmann - Concepedia

Author

Steffen Borrmann

Also Known As

Anders Björkman, Borrmann S., Borrmann, Steffen, Julia Bielicki, Maciej F Boni, Maciej F. Boni, S Borrmann, S. Borrmann, STEFFEN BORRMANN, Sourakatou Salifou

152

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

University of Tübingen Kenya Medical Research Institute Albert Schweitzer Hospital Heidelberg University German Center for Infection Research

About

Steffen Borrmann is an author at University of Tübingen specializing in medicine, malaria, and parasitology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	29	2.7K
2	Public Health	6	6	595
3	Health Sciences	5	5	358
4	Engineering	1	1	29
5	Nursing	1	1	39

Steffen Borrmann

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Spread of Artemisinin Resistance in <i>Plasmodium falciparum</i> Malaria Elizabeth A. Ashley, Mehul Dhorda, Rick M. Fairhurst, New England Journal of Medicine	2014	2.1K
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing Magnus Manske, Olivo Miotto, Susana Campino, Nature PhylogeneticsMolecular EcologyNext-generation SequencingMalariaDeep Sequencing	2012	523
Long‐Term Treatment of Intestinal Helminths Increases Mite Skin‐Test Reactivity in Gabonese Schoolchildren Anita H.J. van den Biggelaar, Laura C. Rodrigues, Ronald van Ree, The Journal of Infectious Diseases	2004	332
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine Meera Venkatesan, Nahla B. Gadalla, Kasia Stepniewska, American Journal of Tropical Medicine and Hygiene Antiparasitic AgentMalariaGenetic EpidemiologyPharmacotherapyParasite Genomics	2014	292
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial Martin Adjuik, Patrice Agnamey, Ahmed Babiker, The Lancet African ChildrenMalariaPharmacologyPediatricsAmodiaquine-artesunate Versus Amodiaquine	2002	279
Fosmidomycin for malaria Michel A. Missinou, Steffen Borrmann, Andreas Schindler, The Lancet Health SciencesAntibioticsAntiparasitic AgentMedicineMalaria	2002	220
Chloroquine resistance before and after its withdrawal in Kenya Leah Mwai, Edwin Ochong, Abdirahman I. Abdi, Malaria Journal	2009	183
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan <i>Plasmodium falciparum</i> Isolates and Polymorphisms in <i>p</i> <i>fcrt</i> and <i>p</i> <i>fmdr1</i> Leah Mwai, Steven M. Kiara, Abdirahman I. Abdi, Antimicrobial Agents and Chemotherapy	2009	163
Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial Quique Bassat, Modest Mulenga, Halidou Tinto, PLoS ONE	2009	147
Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria Markus S. Mueller, Nyabuhanga Runyambo, Irmela Wagner, Transactions of the Royal Society of Tropical Medicine and Hygiene Antiparasitic AgentMalariaPharmacotherapyDrug ResistanceMedicinal Chemistry	2004	145

Page 1